ENTA position history
The shares of Enanta Pharmaceuticals (ENTA) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 1,995,000 shares, $113M, 0.57% of portfolio
- 2021 Q4: 1,573,829 shares, $118M, 0.63% of portfolio, Reduce −21.1%
- 2022 Q1: 1,550,000 shares, $110M, 0.59% of portfolio, Reduce −1.5%
- 2022 Q2: 1,550,000 shares, $73M, 0.45% of portfolio
- 2022 Q3: 1,550,000 shares, $80M, 0.48% of portfolio
- 2022 Q4: 1,550,000 shares, $72M, 0.47% of portfolio
- 2023 Q1: 1,550,000 shares, $63M, 0.35% of portfolio
- 2023 Q2: 1,875,000 shares, $40M, 0.22% of portfolio, Add +21.0%
- 2023 Q3: 1,875,000 shares, $21M, 0.10% of portfolio
- 2023 Q4: 2,025,000 shares, $19M, 0.09% of portfolio, Add +8.0%
- 2024 Q1: 4,190,000 shares, $73M, 0.33% of portfolio, Add +106.9%
- 2024 Q2: 2,095,000 shares, $27M, 0.13% of portfolio, Reduce −50.0%
- 2024 Q3: 2,108,262 shares, $22M, 0.11% of portfolio, Add +0.6%
- 2024 Q4: 2,108,262 shares, $12M, 0.06% of portfolio
- 2025 Q1: 2,122,262 shares, $12M, 0.07% of portfolio, Add +0.7%
- 2025 Q2: 2,122,262 shares, $16M, 0.07% of portfolio
- 2025 Q3: 4,244,524 shares, $51M, 0.21% of portfolio, Add +100.0%
- 2025 Q4: 2,772,262 shares, $44M, 0.21% of portfolio, Reduce −34.7%
- 2026 Q1: 2,871,862 shares, $36M, 0.21% of portfolio, Add +3.6%
- 2026 Q2: 2,418,202 shares, $35M, 0.16% of portfolio, Reduce −15.8%
- 2026 Q3: 950,000 shares, $13M, 0.05% of portfolio, Reduce −60.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|